JTC supports open, responsible data sharing for thyroid cancer research. Authors should deposit data and code in trusted repositories when possible, with clear access instructions.

We recognize that clinical datasets require controlled access due to patient privacy, consent, or regulatory constraints. Authors should document restrictions and access pathways.

• Clinical data repositories with controlled access and data use agreements
• Genomics repositories such as GEO, SRA, or EGA
• Proteomics repositories such as ProteomeXchange
• Imaging repositories for radiology or pathology data
• Code repositories such as GitHub or GitLab with release tags

Patient identifiers must be removed and data should be deidentified in line with applicable privacy regulations. When full sharing is not possible, provide deidentified summaries and clear instructions for requesting access.

Authors should document data governance, including custodians, access review procedures, and consent limits.

• Include repository links or accession numbers in the manuscript
• State licensing terms for data and code when applicable
• Provide documentation for custom scripts or pipelines
• Describe any access restrictions and approval requirements

JTC is committed to rigorous, transparent publishing in thyroid cancer research and care. We emphasize reproducible clinical methods, clear reporting of diagnostic criteria, and ethical compliance across all article types.

The editorial office supports authors, editors, and reviewers with clear guidance and responsive communication. For questions about scope or workflow, contact [email protected].

We encourage continuous improvement in reporting practices and share updates that help the community maintain high standards in endocrine oncology, surgical outcomes, and translational thyroid research.